New MS treatment trial compares stem cell transplantation to best available drugs

(NIH/National Institute of Allergy and Infectious Diseases) A clinical trial has begun testing an experimental stem cell treatment against the best available biologic therapies for severe forms of relapsing multiple sclerosis (MS). The trial, sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, will compare the safety, efficacy and cost-effectiveness of the two therapeutic approaches.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news